XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Collaboration Agreements, License Agreement and Revenues - Eluminex Agreement - Additional Information 2 (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jul. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Total revenue   $ 60,827 $ 38,429
Eluminex [Member]      
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Aggregate consideration received for milestone and upfront payments $ 8,000    
Future manufacturing clinical regulatory and commercial milestone payments 64,000    
Commercial milestone $ 36,000    
Eluminex [Member] | Cornea Products [Member] | ASC 606 [Member]      
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Percentage of product manufacturing costs until manufacturing technology fully transferred   110.00%